DETECTION OF LOSS OF HETEROZYGOSITY OF P53 GENE IN PARAFFIN-EMBEDDED BREAST CANCERS BY NONISOTOPIC PCR-SSCP

被引:5
作者
CHEN, YH [1 ]
LI, CD [1 ]
YAP, EPH [1 ]
MCGEE, JOD [1 ]
机构
[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND
关键词
BREAST CANCER; P53; POLYMORPHISM; LOSS OF HETEROZYGOSITY;
D O I
10.1002/path.1711770205
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A rapid non-isotopic PCR-SSCP (polymerase chain reaction-single-stranded conformation polymorphism) method was developed in this study to detect polymorphism and loss of heterozygosity (LOH) of p53 in formalin-fixed and paraffin-embedded samples of normal breast tissue and of breast cancer. p53 expression was also examined by immunohistochemistry. In 35 paired samples, heterozygosity in exon 3 of p53 was detected in 17 cases (49 per cent) and LOH of the p53 gene in breast cancer tissues was observed in 7 out of 15 informative cases (47 per cent). The correlation of LOH of p53 with positive p53 immunostaining did not reach statistical significance, but all immunostaining-positive rumours among informative cases had LOH of p53. The results support the hypothesis that in most cases the allelic deletion of p53 may uncover the 'recessive mutation' in the remaining allele. However, LOH of p53 was more frequent than positive immunostaining and was significantly associated with poor differentiation of breast cancer (P<0.05). The results suggest that the allelic deletion of p53 may also contribute to the development and progression of breast cancer by reducing the amount of normal p53 protein. These results show that non-isotopic PCR-SSCP is a simple, fast, and effective method for detecting polymorphism and LOH of the p53 gene, which is especially useful for retrospective studies.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 19 条
[1]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[2]   HETEROGENEITY FOR ALLELIC LOSS IN HUMAN BREAST-CANCER [J].
CHEN, LC ;
KURISU, W ;
LJUNG, BM ;
GOLDMAN, ES ;
MOORE, D ;
SMITH, HS .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (07) :506-510
[3]  
CHEN LC, 1991, P NATL ACAD SCI USA, V88, P3874
[4]  
CHEN YH, 1993, J PATHOL S, V169, P153
[5]   GENETIC-BASIS FOR P53 OVEREXPRESSION IN HUMAN BREAST-CANCER [J].
DAVIDOFF, AM ;
HUMPHREY, PA ;
IGLEHART, JD ;
MARKS, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :5006-5010
[6]  
FULTS D, 1989, CANCER RES, V49, P6572
[7]   LOCALIZATION OF GENE FOR HUMAN P53 TUMOR-ANTIGEN TO BAND 17P13 [J].
ISOBE, M ;
EMANUEL, BS ;
GIVOL, D ;
OREN, M ;
CROCE, CM .
NATURE, 1986, 320 (6057) :84-85
[8]   THE P53 TUMOR SUPPRESSOR GENE [J].
LEVINE, AJ ;
MOMAND, J ;
FINLAY, CA .
NATURE, 1991, 351 (6326) :453-456
[9]   PRIMARY STRUCTURE POLYMORPHISM AT AMINO-ACID RESIDUE-72 OF HUMAN-P53 [J].
MATLASHEWSKI, GJ ;
TUCK, S ;
PIM, D ;
LAMB, P ;
SCHNEIDER, J ;
CRAWFORD, LV .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (02) :961-963
[10]   THE GENE FOR HUMAN P53 CELLULAR TUMOR-ANTIGEN IS LOCATED ON CHROMOSOME-17 SHORT ARM (17P13) [J].
MCBRIDE, OW ;
MERRY, D ;
GIVOL, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (01) :130-134